In mid-April, OpenAI launched a powerful new AI model, GPT-4.1, which it claimed “excelled” at following instructions. But the results of several independent tests suggest the model is less aligned — ...

One dollar doesn’t go nearly as far as it used to. According to online inflation data, $1 in December 2015 would need to be $1.37 in December 2025 to have the same buying power. Even so, there are ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced dosing maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between doses.

As recently as 2021, almost half of all U.S. mansions — homes with at least 5,000 square feet of livable space — cost $1 million or less. But today, only a handful of cities still offer top-end homes ...

With off‑label use surging, it’s virtually impossible to know how many people are currently taking GLP‑1 drugs like Wegovy or Mounjaro, or how many will be prescribed them in the years ahead. The same ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...